<DOC>
	<DOCNO>NCT00238472</DOCNO>
	<brief_summary>This study conduct United States . The purpose study evaluate effect nateglinide compare glibenclamide renal hemodynamics albumin excretion .</brief_summary>
	<brief_title>A Pilot Study Evaluate Effects Nateglinide vs. Glibenclamide Renal Hemodynamics Albumin Excretion</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Nateglinide</mesh_term>
	<mesh_term>Glyburide</mesh_term>
	<criteria>Type 2 diabetes diagnose least 1 year inclusion Blood glucose criterion must meet Microalbuminuria criterion must meet Pregnant nursing female females childbearing potential use medically approve birth control method Blood glucose criterion outside specify range Microalbuminuria criterion outside specify range Serious cardiovascular event within past 6 month Other protocoldefined exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Type 2 diabetes</keyword>
	<keyword>nateglinide</keyword>
</DOC>